Kim DW, Gu N, Lee H, Jang IJ, Chu K, Yu KS, et al. Usefulness of oral loading of oxcarbazepine suspension in selected patients with epilepsy. Int J Clin Pharmacol Ther. 2013 Oct;51(10):780-6. doi: 10.5414/CP201896.

Cha Y-J, Lee H, Gu N, Kim T-E, Lim KS, Yoon SH, Chung J-Y, Jang I-J, Shin S-G, Yu K-S, Cho J-Y. Sustained Increase in the Oral Bioavailability of Loperamide after a Single Oral Dose of HM30181, a P-glycoprotein Inhibitor, in Healthy Male Participants. Basic Clin Pharmacol Toxicol. 2013;113(6):419-424.

Lee H, Jang I-J, Yu K-S, Choi J, Oh B-H. A Population Pharmacokinetic Analysis of Fimasartan, a Selective Angiotensin II Receptor Antagonist, in Healthy Caucasian Subjects and Korean Patients With Hypertension. Clinical Pharmacology in Drug Development. 2013;2(2):162-72. doi: 10.1002/cpdd.10.

Lee H, Kim KS, Chae SC, Jeong MH, Kim DS, Oh BH. Ambulatory Blood Pressure Response to Once-Daily Fimasartan: An 8-Week, Multicenter, Randomized, Double-Blind, Active-Comparator, Parallel-Group Study in Korean Patients With Mild To Moderate Essential Hypertension. Clin Ther. 2013;35(9):1337-49. doi: 10.1016/j.clinthera.2013.06.021.

Lee H, Yang H-M, Lee H-Y, Kim J-J, Choi D-J, Seung K-B, Jeon E-S, Ha J-W, Rim S-J, Park JB, Shin J-H, Oh B-H. Efficacy and Tolerability of Once-Daily Oral Fimasartan 20 to 240 mg/d in Korean Patients with Hypertension: Findings from Two Phase II, Randomized, Double-Blind, Placebo-Controlled Studies. Clin Ther. 2012;34(6):1273-1289.

Chi YH, Lee H, Paik SH et al. Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fimasartan, a Novel Angiotensin II Receptor Antagonist, Following Single and Repeated Oral Administration in the Fasted and Fed States in Healthy Subjects. Am J Cardiovasc Drugs. 2011 Oct 1. 1(5):335-46.

Xie HG, Cao YJ, Gauda EB, Agthe AG, Hendrix CW, Lee H. Clonidine Clearance Matures Rapidly during the Early Postnatal Period: A Population Pharmacokinetic Analysis in Newborns with Neonatal Abstinence Syndrome. J Clin Pharmacol. 2011:51:502-511.

Park CG, Lee H, Choi JW, Lee SJ, Kim SH, Lim HE. Non-concurrent Dosing Attenuated Pharmacokinetic Drug Interaction between Amlodipine and Simvastatin. Int J Clin Pharmacol Ther. 2010; 48(8):497-503.

Xu Z, Lee H, Vu T, Hu C, Yan H, Baker D, Hsu B, Pendley C, Wagner C, Davis HM, Zhou H. Population Pharmacokinetics of Golimumab in Patients with Ankylosing Spondylitis: Impact of Body Weight and Immunogenicity. Int J Clin Pharmacol Ther. 2010;48(9):596-607.

Xu Z, Vu T, Lee H, Hu C, Ling J, Yan H, Baker D, Beutler A, Pendley C, Wagner C, Davis HM, Zhou H. Population Pharmacokinetics of Golimumab, an Anti-Tumor Necrosis Factor-Alpha Human Monoclonal Antibody, in Patients with Psoriatic Arthritis. J Clin Pharmacol, 2009;49:1056-1070.

Lee H. Chapter 12. Utilizing the Preclinical Database to Support Clinical Drug Development. In: Preclinical Drug Development, edited by Mark Rogge and David R. Taft, Taylor & Francis, Boca Raton, London, New York, Singapore. 2005 & 2009 (2nd ed.) (ISBN: 978-1420084726)

Lee H. Chapter 13. Regulation for Drug Development and Competition. In: Introduction to Pharmaceutical Medicine, Novo Consulting, Seoul, 2009